Home Biosimilar Antibodies Others Others antibody Feladilimab (Anti-ICOS / CD278) For research use only.
Not for use in humans.

Feladilimab (Anti-ICOS / CD278)

Synonyms: GSK3359609

Feladilimab (Anti-ICOS/CD278) is humanized IgG4 anti-ICOS agonist monoclonal antibody. Feladilimab binds to ICOS-expressing T cells. Feladilimab has potential for its use in cancer research. MW: 145.5 KD.

Feladilimab (Anti-ICOS / CD278)

Purity & Quality Control

Batch: A246201 Purity: 99% Protein concentration: 8.65mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Feladilimab (Anti-ICOS/CD278) is humanized IgG4 anti-ICOS agonist monoclonal antibody. Feladilimab binds to ICOS-expressing T cells. Feladilimab has potential for its use in cancer research. MW: 145.5 KD.

Product Details

CAS No. 2252518-85-5
Molecular Weight 145.5 kDa
Isotype Human IgG4PE
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Feladilimab (Anti-ICOS / CD278) | Feladilimab (Anti-ICOS / CD278) supplier | purchase Feladilimab (Anti-ICOS / CD278) | Feladilimab (Anti-ICOS / CD278) cost | Feladilimab (Anti-ICOS / CD278) manufacturer | order Feladilimab (Anti-ICOS / CD278) | Feladilimab (Anti-ICOS / CD278) distributor